Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Angiotech hands $363M in interventional assets back to Argon Medical
Angiotech Pharmaceuticals sells its interventional products business back to previous overseer Argon Medical for $362.5 million, planning to use part of the funds to repay repay all of its outstanding debts.
2. BioControl Medical makes progress toward FDA review for CardioFit heart stim device
The FDA approves the 3rd and largest phase of BioControl Medical’s investigational device exemption trial of the CardioFit vagal nerve stimulation device.
1. EXCLUSIVE: Former Sen. Brown tells medtech to “demand the real vote” on medical device tax repeal
Former Sen. Scott Brown (R-Mass.) tells MassDevice.com in an exclusive interview that the medical device industry should demand a real vote to repeal the 2.3% medical device sales tax, rather than settle for the latest symbolic victory in the Senate.
